NEULANDLABNSENeuland Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Thu, 2 Jul · 16:00 IST

Routine filing: quarterly demat and remat certificate submitted

NEULANDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.3%1-day move
₹18992.00
prior close
₹19100.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.6-1.3-1.5-1.0-0.3-0.4+0.0+3.0+2.6+0.0-2.3
Up moveDown movePending
AI summary

Neuland Laboratories submitted a routine quarterly certificate to BSE and NSE under SEBI Regulation 74(5) for the quarter ended June 30, 2026. The certificate was issued by its Registrar and Share Transfer Agent Kfin Technologies, confirming that details of shares dematerialized and rematerialized during the quarter have been furnished to the stock exchanges. This is a standard compliance requirement with no material financial impact.

Likely market impact

Routine regulatory compliance filing; no impact on shareholders or stock price.